The missing voice of patients in drug-safety reporting.
作者信息
Basch Ethan
机构信息
Health Outcomes Group, Memorial Sloan-Kettering Cancer Center, New York, USA.
出版信息
N Engl J Med. 2010 Mar 11;362(10):865-9. doi: 10.1056/NEJMp0911494.
Abstract
摘要
相似文献
1
The missing voice of patients in drug-safety reporting.药物安全报告中患者缺失的声音。
N Engl J Med. 2010 Mar 11;362(10):865-9. doi: 10.1056/NEJMp0911494.
2
Regulatory experts debate FDA's authority.监管专家就美国食品药品监督管理局的权限展开辩论。
Am J Health Syst Pharm. 2007 May 1;64(9):910, 912. doi: 10.2146/news070040.
3
The future of population-based postmarket drug risk assessment: a regulator's perspective.基于人群的上市后药物风险评估的未来：监管者视角。
Clin Pharmacol Ther. 2013 Sep;94(3):349-58. doi: 10.1038/clpt.2013.118. Epub 2013 Jun 5.
4
Impact of new regulations for pediatric labeling by the Food and Drug Administration.美国食品药品监督管理局儿科标签新规的影响。
Pediatr Nurs. 2000 Jan-Feb;26(1):95-6.
5
[Direct reporting by patients of adverse drug reactions in Spain].[西班牙患者对药物不良反应的直接报告]
Farm Hosp. 2013 Jan-Feb;37(1):65-71. doi: 10.7399/FH.2013.37.1.121.
6
Flight 483 now boarding.483号航班正在登机。
Altern Med Rev. 2010 Sep;15(3):183-5.
7
Review of FDA Amendments Act Section 921 Experience in Posting Data-mining Results from the FAERS Database.美国食品和药物管理局修正案第 921 节对 FAERS 数据库数据挖掘结果公布经验的审查。
Clin Ther. 2021 Feb;43(2):380-395. doi: 10.1016/j.clinthera.2020.12.011. Epub 2021 Jan 24.
8
Reporting Adverse Drug Events.报告药品不良事件。
Am J Gastroenterol. 2019 Sep;114(9):1411-1413. doi: 10.14309/ajg.0000000000000374.
9
New FDA regulation to improve safety reporting in clinical trials.美国食品药品监督管理局（FDA）出台新规定以改善临床试验中的安全报告。
N Engl J Med. 2011 Jul 7;365(1):3-5. doi: 10.1056/NEJMp1103464. Epub 2011 Jun 8.
10
Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels.仿制药与品牌药制造商因产品标签不充分而承担的法律责任。
JAMA. 2018 Aug 14;320(6):547-548. doi: 10.1001/jama.2018.8408.
引用本文的文献
1
Electronic Patient-Reported Outcome Quality of Life Score in Japanese Patients With Pancreatic Cancer on Second-Line Chemotherapy: A Multicenter Observational Study.日本胰腺癌患者二线化疗中电子患者报告的生活质量评分：一项多中心观察性研究。
Cancer Med. 2025 Sep;14(17):e71161. doi: 10.1002/cam4.71161.
2
Effectiveness of symptom monitoring on electronic patient-reported outcomes (ePROs) among patients with lung cancer: a systematic review and meta-analysis.症状监测对肺癌患者电子患者报告结局（ePROs）的有效性：一项系统评价和荟萃分析。
NPJ Digit Med. 2025 Jul 3;8(1):399. doi: 10.1038/s41746-025-01812-x.
3
A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controls.一项针对前列腺癌患者和对照组的全国性纵向患者报告结局收集研究。
Qual Life Res. 2025 Jul 2. doi: 10.1007/s11136-025-04017-7.
4
Quality of Life of Lung Cancer Patients with Immune-Related Endocrinopathies During Immunotherapy: A Prospective Study Based on the EORTC QLQ-C30 and QLQ-LC13 Questionnaires in Romania.免疫治疗期间患有免疫相关内分泌病的肺癌患者的生活质量：一项基于罗马尼亚EORTC QLQ-C30和QLQ-LC13问卷的前瞻性研究。
Curr Oncol. 2025 Jun 5;32(6):332. doi: 10.3390/curroncol32060332.
5
ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled Trial.ENABLE：基于应用程序的乳腺癌患者报告的生活质量、不良事件及治疗满意度的数字采集与干预：一项随机对照试验方案
JMIR Res Protoc. 2025 May 26;14:e69855. doi: 10.2196/69855.
6
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study.III期CASPIAN研究中广泛期小细胞肺癌患者自我报告的不良事件。
Future Oncol. 2025 May;21(12):1511-1523. doi: 10.1080/14796694.2025.2491297. Epub 2025 May 7.
7
Extraction of First Permanent Molars in Children-A Comprehensive Review of History, Aim, Space Closure and Other Consequences.儿童第一恒磨牙拔除——历史、目的、间隙关闭及其他后果的综合综述
J Clin Med. 2025 Mar 25;14(7):2221. doi: 10.3390/jcm14072221.
8
Prevalence of symptomatic toxicities for novel therapies in adult oncology trials: a scoping review.成人肿瘤学试验中新型疗法的症状性毒性发生率：一项范围综述
JNCI Cancer Spectr. 2025 Apr 30;9(3). doi: 10.1093/jncics/pkaf036.
9
Putting Patients First: Pragmatic Trials in Gynecologic Oncology.将患者放在首位：妇科肿瘤学中的务实试验
Curr Oncol. 2025 Feb 27;32(3):139. doi: 10.3390/curroncol32030139.
10
Exploring Usability of a Clinical Decision Support System for Cancer Care: A User-Centered Study.探索癌症护理临床决策支持系统的可用性：一项以用户为中心的研究。
Cancer Rep (Hoboken). 2025 Mar;8(3):e70173. doi: 10.1002/cnr2.70173.
本文引用的文献
1
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.患者与临床医生报告的不良症状事件：与临床结局的关系
J Natl Cancer Inst. 2009 Dec 2;101(23):1624-32. doi: 10.1093/jnci/djp386. Epub 2009 Nov 17.
2
Agreement between patient-reported symptoms and their documentation in the medical record.患者报告的症状与其病历记录之间的一致性。
Am J Manag Care. 2008 Aug;14(8):530-9.
3
Patient-reported medication symptoms in primary care.初级保健中患者报告的用药症状。
Arch Intern Med. 2005 Jan 24;165(2):234-40. doi: 10.1001/archinte.165.2.234.
4
Better reporting of harms in randomized trials: an extension of the CONSORT statement.随机试验中不良事件的更好报告：CONSORT声明的扩展
Ann Intern Med. 2004 Nov 16;141(10):781-8. doi: 10.7326/0003-4819-141-10-200411160-00009.
Zotero 插件